<DOC>
	<DOCNO>NCT00244322</DOCNO>
	<brief_summary>The purpose study determine : - The safety LY450139 dihydrate side effect might associate . - How much LY450139 dihydrate give long may detect blood . - To determine LY450139 dihydrate may effect protein find blood , call A beta . This protein study subject Alzheimer 's disease . - To collect store sample blood spinal fluid research relate Alzheimer 's disease similar ( neurodegenerative ) diseases inflammation ( irritation ) may provide information subject respond LY450139 medication . Length study : Approximately 29 week . Number office visit : 11 subject : initial visit , every week 14 week study drug treatment , 2 follow-up visit . At cost , approximately 45 eligible participant receive : - Study medication - Study-related diagnostic laboratory evaluation</brief_summary>
	<brief_title>Effects LY450139 Dihydrate Subjects With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>At least 50 year age diagnose mild moderate probable Alzheimer 's disease Fluent read speak English reliable study partner ( caregiver ) ( someone frequent contact make sure study medication take correctly ) . If currently treat certain drug Alzheimer 's disease , dose must least last 2 month prior start study drug . Can currently use require MAOI antidepressant ( selegiline Eldepryl ( R ) ) , antipsychotic , benzodiazepine , calcium channel blocker heart disease , propanolol . Can clinically significant and/or uncontrolled condition significant disease , include condition require treatment warfarin heparin ; currently peptic ulcer , reflux disease , gastrointestinal ( GI ) bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>